Saturday, January 21, 2017
CytoSorbents Launches VetResQ™ for U.S. Veterinary Market.
CytoSorbents Launches VetResQ™ for U.S. Veterinary Market. CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces the marketing launch and commercial availability of the VetResQ™ sorbent cartridge for the United States veterinary market.
VetResQ is a broad spectrum blood purification adsorber designed to help treat deadly inflammation and toxic injury in animals with critical illnesses such as septic shock, toxic shock syndrome, severe systemic inflammation, toxin-mediated diseases, pancreatitis, trauma, liver failure, and drug intoxication. source
Subscribe to:
Post Comments (Atom)
Agribusiness Millionaires
Learn how to make money in agribusiness.
Popular Posts
-
Caffeine abuse common among English Premier League footballers : Follow-up investigations to recent widespread doping allegations attached...
-
A study recently published in the journal PLOS Neglected Tropical Diseases, shows that the cattle disease nagana, also called African ani... -
Germany's top institute for infectious diseases pulled its own paper which claimed a vaccine could be available this fall. The Robert K...
-
If you are vegetarian, chances are, you are feeding your pet home-cooked vegetarian food. But the fact is, dogs are different from human... -
What is Lyme disease? Lyme disease or Lyme borreliosis is an infectious tick-borne disease, caused by the Borrelia spirochete, a gram-negat...
-
Zebra Technologies develops new traceability scanning device : Zebra Technologies has launched a mobile scanning device which may improve me...
Claim your bonus here..
Free dog care guide.
CASSAVA BUSINESS
CASSAVA FLAKES.
No comments:
Post a Comment